1. Home
  2. ERIE vs WAT Comparison

ERIE vs WAT Comparison

Compare ERIE & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erie Indemnity Company

ERIE

Erie Indemnity Company

HOLD

Current Price

$296.79

Market Cap

19.2B

Sector

Finance

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$394.93

Market Cap

17.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERIE
WAT
Founded
1925
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
19.2B
17.4B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
ERIE
WAT
Price
$296.79
$394.93
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$382.14
AVG Volume (30 Days)
131.9K
531.7K
Earning Date
10-30-2025
11-04-2025
Dividend Yield
1.84%
N/A
EPS Growth
15.90
3.82
EPS
12.39
10.88
Revenue
$4,040,325,000.00
$3,105,638,000.00
Revenue This Year
$9.98
$7.96
Revenue Next Year
$5.75
$6.32
P/E Ratio
$23.93
$36.30
Revenue Growth
9.53
6.90
52 Week Low
$276.91
$275.05
52 Week High
$456.93
$423.56

Technical Indicators

Market Signals
Indicator
ERIE
WAT
Relative Strength Index (RSI) 49.40 61.33
Support Level $292.47 $386.09
Resistance Level $301.14 $403.80
Average True Range (ATR) 5.59 9.63
MACD 2.03 -1.66
Stochastic Oscillator 71.66 53.55

Price Performance

Historical Comparison
ERIE
WAT

About ERIE Erie Indemnity Company

Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: